Search

everythinglearnresearchcommunity

for

Search:↓

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

ROXY proteins help plants respond to nitrate shortage by affecting nutrient sensing and growth.

The protein CCN2 controls hair growth by affecting hair follicle formation and stem cell activity in mice.

Vitamin C derivative may promote hair growth by activating specific genes.

A new mouse mutation causes skin and hair defects due to a gene change.

Removing integrin α3β1 from hair stem cells lowers skin tumor growth by affecting CCN2 protein levels.

Higher levels of CCL7 are linked to more severe hair loss in alopecia areata patients.

CCL5 is important for the hair growth potential of human dermal papilla cells.

CCCA is a scarring hair disorder mainly affecting people of African descent, needing better awareness and treatment.

CCDC22 and CCDC93 are essential for root and root hair growth in Arabidopsis.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

Human prostate cells produce more WISP1/CCN4 when there's not enough oxygen.

CCCA is a common hair loss condition in African American women, often inherited and influenced by hairstyling, with unique scalp features detectable by special tools.

848 genes related to fat and metabolism are less active in people with Central Centrifugal Cicatricial Alopecia.

CCCA and lichen planopilaris have similar histological features, making them hard to distinguish.

Blocking the CCR5 receptor may be a new way to treat hair loss from alopecia areata.

A specific DNA sequence caused hair loss in male mice by activating immune cells and increasing a certain immune signal.

Cronkhite-Canada syndrome is a rare, non-inherited condition causing various symptoms like polyps, hair loss, and weight loss.

SIPHL1 from tomato enhances plants' response to low phosphate levels.

CCCA is a hair loss type affecting African women, possibly caused by grooming and chemicals, with various treatments and needing more research.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

Hair breakage may be an early sign of a hair loss condition called CCCA in African American women.

The document concludes that better treatments for CCCA are needed and more research is required to understand its causes related to hairstyling and genetics.

Diagnose and manage CCCA with thorough history, exams, and labs; treat with anti-inflammatory agents, stress reduction, and stopping harmful hair practices.

Longer hair loss leads to more severe CCCA; early treatment and avoiding damaging hairstyles help regrowth.

Hair transplants can effectively treat hair loss from CCCA in African American women if there's no inflammation.

CCCA is a common scarring hair loss in African descent women, possibly linked to genetics, hair care practices, and health issues like diabetes.

The conclusion is that hair loss from CCCA may be genetic and not solely caused by hair grooming practices.

CK15 is not a reliable marker for stem cells in damaged hair follicles from patients with CCCA.

Some people's hair loss is caused by multiple factors, with the most common being a mix of AGA and CCCA.